4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-016131
CEO and CFO bought 6,000 shares at $8.55 ($51,300)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-06-07 | Purchase | +6,000 | $8.55 | $51,300 | 1,238,953 | D |
| Open-market purchases · 6,000 sh · avg $8.55 · $51,300 | |||||||
Loading xslF345X03/ownership.xml…